Want to join the conversation?
$REGN 2Q15 Call: Has 15 antibodies that are in clinical development and has late-stage programs in five different therapeutic areas; Sarilumab for rheumatoid arthritis; Dupilumab for atopic dermatitis and asthma; Fasinumab for pain; and REGN2222 for respiratory syncytial virus.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.